Delivery Order SPE2DB22D2007-SPE2DB25FJ2DC
Award Date
6/9/25
Potential Completion Date
7/1/25
Potential Value
$125K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a ceiling value of $49,926.80 and a performance period ending on May 23, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has a ceiling value of $178,310.12 and is a firm fixed price contract. The contract is not set aside and is therefore open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 15 mg capsules. The contract has a ceiling value of $18,722.57 and a period of performance through May 23, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $199,707.28, is a delivery order for the supply of REVLIMID 10 MG CAPSULE 28S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 25 mg capsules. The contract has a ceiling value of $89,155.06 and a completion date of June 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of REVLIMID 15 MG CAPSULE 100S, a prescription medication, to support military and government healthcare programs. The contract has a ceiling value of $89,155.06 and is a firm fixed price, delivery order contract. It is not set aside for any specific business type. The contract is associated with a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 28S, a prescription medication, with a ceiling value of $74,890.20. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Revlimid 10 mg capsules, a prescription medication. The contract has a ceiling value of $68,649.37 and is a firm fixed-price delivery order, with a performance period ending on May 8, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,890.20 firm fixed-price delivery order is for the supply of REVLIMID 10 MG CAPSULE 28S, a prescription medication. The award has an ultimate completion date of May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,155.06, is for the delivery of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. The contract was awarded on February 13, 2025 and does not have a set-aside designation,...